Bionano Genomics, Inc. (BNGO) vs Cellectar Biosciences, Inc. (CLRB)
A side-by-side comparison of Bionano Genomics, Inc. and Cellectar Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BNGO
Bionano Genomics, Inc.
$1.46HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
CLRB
Cellectar Biosciences, Inc.
$1.61HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
Total return — BNGO vs CLRB
growth of $100 · dividends reinvested · last 8yBNGO -100.0% (-62.5%/yr)CLRB -99.7% (-51.7%/yr)CLRB compounded faster over this window
Log scale — wide-divergence pair
BNGO CLRB
BNGO vs CLRB: by the numbers
- •BNGO is the larger company ($17M vs $13M market cap).
- •Both run net losses; CLRB's is the smaller (0.00% vs -106.58% net margin).
Metrics side by side
Valuation
| Metric | BNGO | CLRB |
|---|---|---|
| P/S ratio | 0.55 | N/A |
| P/B ratio | 0.53 | 0.43 |
Profitability
| Metric | BNGO | CLRB |
|---|---|---|
| Gross margin | 21.95% | 0.00% |
| Operating margin | -116.95% | 0.00% |
| Net margin | -106.58% | 0.00% |
| ROE | -101.76% | -74.73% |
| ROIC | -85.72% | -74.94% |
Growth (annualized)
| Metric | BNGO | CLRB |
|---|---|---|
| Revenue CAGR (5Y) | 17.97% | N/A |
| Total return CAGR (5Y) | -78.37% | -60.51% |
Frequently asked
- How have BNGO and CLRB total returns compared?
- Over the past 5 years, BNGO delivered -78.37% and CLRB delivered -60.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bionano Genomics ROECellectar Biosciences ROEBionano Genomics operating marginCellectar Biosciences operating marginBionano Genomics revenue growthCellectar Biosciences revenue growthBionano Genomics free cash flowCellectar Biosciences free cash flow
Bionano Genomics & Cellectar Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.